{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:27:12Z","timestamp":1788794832224,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) affects one-third of the global population. Despite its high prevalence, there is a lack of minimally non-invasive diagnostic methods to assess this condition. This study explores the potential of circulating microRNAs (miRNAs) as diagnostic biomarkers for MASLD after a 2-year nutritional intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Fifty-five subjects with steatosis (MASLD group) from the Fatty Liver in Obesity (FLiO) study (NCT03183193) were analyzed at baseline and after 6, 12 and 24 months. Participants were classified into two groups: those who still had steatosis after the intervention (unhealthy group) and those in whom steatosis had disappeared (healthy group). Hepatic status was evaluated through magnetic resonance imaging (MRI), ultrasonography, elastography and serum transaminases. Circulating miRNA levels were measured by RT-PCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The dietary intervention was able to modulate the expression of circulating miRNAs after 6, 12, and 24 months. Logistic regression analyses revealed that the most effective panels for diagnosing whether MASLD has disappeared after the nutritional intervention included miR15b-3p, miR126-5p and BMI (AUC 0.68) at 6 months, miR29b-3p, miR122-5p, miR151a-3p and BMI (AUC 0.85) at 12 months and miR21-5p, miR151a-3p and BMI at 24 months (AUC 0.85).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Circulating miRNAs were useful in predicting MASLD in subjects with overweight or obesity after following a weight-loss oriented nutritional intervention. These findings highlight the potential role of miRNAs in diagnosing MASLD and underscore the importance of precision nutrition in managing and determining MASLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial registration<\/jats:title>\n            <jats:p>Trial registration number: NCT03183193 (www.clinicaltrials.gov).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-024-02499-9","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:57:04Z","timestamp":1731733024000},"page":"987-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4484-8819","authenticated-orcid":false,"given":"Ana Luz","family":"Tobaruela-Resola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-8457","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Riezu-Boj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-9916","authenticated-orcid":false,"given":"Ferm\u00edn I.","family":"Milagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-312X","authenticated-orcid":false,"given":"Paola","family":"Mogna-Pelaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9076-6717","authenticated-orcid":false,"given":"Jos\u00e9 I.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-3629","authenticated-orcid":false,"given":"Mariana","family":"Elorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-0092","authenticated-orcid":false,"given":"Alberto","family":"Benito-Boillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-0761","authenticated-orcid":false,"given":"Josep A.","family":"Tur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-6941","authenticated-orcid":false,"given":"J. Alfredo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6475-5387","authenticated-orcid":false,"given":"Itziar","family":"Abete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-0892","authenticated-orcid":false,"given":"Mar\u00eda \u00c1ngeles","family":"Zulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"11","key":"2499_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/liv.15740","volume":"43","author":"P Aspichueta","year":"2023","unstructured":"Aspichueta P, Zeisel MB (2023) miR-21p-5p coordinates biological pathways to promote MASLD progression. Liver Int 43(11):2343\u20132345. https:\/\/doi.org\/10.1111\/liv.15740","journal-title":"Liver Int"},{"key":"2499_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad175","author":"SJ Mart\u00ednez-Dom\u00ednguez","year":"2023","unstructured":"Mart\u00ednez-Dom\u00ednguez SJ, Garc\u00eda-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, Callau P, Mendi C et al (2023) Inflammatory bowel disease is an independent risk factor for metabolic dysfunction-Associated Steatotic Liver Disease in lean individuals. https:\/\/doi.org\/10.1093\/ibd\/izad175. Inflamm Bowel Dis izad175","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2499_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/biomedicines11082108","volume":"11","author":"K Staufer","year":"2023","unstructured":"Staufer K, Stauber RE (2023) Steatotic liver disease: metabolic dysfunction, Alcohol, or both? Biomedicines 11(8):2108. https:\/\/doi.org\/10.3390\/biomedicines11082108","journal-title":"Biomedicines"},{"key":"2499_CR4","doi-asserted-by":"publisher","first-page":"153303382312194","DOI":"10.1177\/15330338231219434","volume":"22","author":"SA Bhat","year":"2023","unstructured":"Bhat SA, Farooq Z, Ismail H, Corona-Avila I, Khan MW (2023) Unraveling the Sweet secrets of HCC: glucometabolic rewiring in Hepatocellular Carcinoma. Technol Cancer Res Treat 22:15330338231219434. https:\/\/doi.org\/10.1177\/15330338231219434","journal-title":"Technol Cancer Res Treat"},{"issue":"11","key":"2499_CR5","doi-asserted-by":"publisher","first-page":"e0298","DOI":"10.1097\/HC9.0000000000000298","volume":"7","author":"J Bai","year":"2023","unstructured":"Bai J, Zhu L, Mi W, Gao Z, Ouyang M, Sheng W et al (2023) Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD. Hepatol Commun 7(11):e0298. https:\/\/doi.org\/10.1097\/HC9.0000000000000298","journal-title":"Hepatol Commun"},{"issue":"1","key":"2499_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1017\/S095442242100038X","volume":"36","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Moon R, Thorne JL, Moore JB (2023) NAFLD and vitamin D: evidence for intersection of microRNA-regulated pathways. Nutr Res Rev 36(1):120\u2013139. https:\/\/doi.org\/10.1017\/S095442242100038X","journal-title":"Nutr Res Rev"},{"issue":"7","key":"2499_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/liv.14818","volume":"41","author":"BA Marin-Alejandre","year":"2021","unstructured":"Marin-Alejandre BA, Cantero I, Perez-Diaz-Del-Campo N, Monreal JI, Elorz M, Herrero JI et al (2021) Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial. Liver Int 41(7):1532\u20131544. https:\/\/doi.org\/10.1111\/liv.14818","journal-title":"Liver Int"},{"issue":"10","key":"2499_CR8","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/nu11102543","volume":"11","author":"BA Marin-Alejandre","year":"2019","unstructured":"Marin-Alejandre BA, Abete I, Cantero I, Monreal JI, Elorz M, Herrero JI et al (2019) The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled trial. Nutrients 11(10):2543. https:\/\/doi.org\/10.3390\/nu11102543","journal-title":"Nutrients"},{"issue":"5","key":"2499_CR9","doi-asserted-by":"publisher","first-page":"166083","DOI":"10.1016\/j.bbadis.2021.166083","volume":"1867","author":"J Wu","year":"2021","unstructured":"Wu J, Nagy LE, Liangpunsakul S, Wang L (2021) Non-coding RNA crosstalk with nuclear receptors in liver disease. Biochim Biophys Acta Mol Basis Dis 1867(5):166083. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166083","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"2499_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clnu.2017.11.014","volume":"38","author":"S Giardina","year":"2019","unstructured":"Giardina S, Hern\u00e1ndez-Alonso P, D\u00edaz-L\u00f3pez A, Salas-Huetos A, Salas-Salvad\u00f3 J, Bull\u00f3 M (2019) Changes in circulating miRNAs in healthy overweight and obese subjects: Effect of diet composition and weight loss. Clin Nutr 38(1):438\u2013443. https:\/\/doi.org\/10.1016\/j.clnu.2017.11.014","journal-title":"Clin Nutr"},{"issue":"6","key":"2499_CR11","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/v14061118","volume":"14","author":"MA Martinez","year":"2022","unstructured":"Martinez MA, Tural C, Franco S (2022) Circulating MicroRNAs as a Tool for diagnosis of Liver Disease Progression in people living with HIV-1. Viruses 14(6):1118. https:\/\/doi.org\/10.3390\/v14061118","journal-title":"Viruses"},{"issue":"11","key":"2499_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/nu9111168","volume":"9","author":"BJ Quintanilha","year":"2017","unstructured":"Quintanilha BJ, Reis BZ, Duarte GBS, Cozzolino SMF, Rogero MM (2017) Nutrimiromics: role of microRNAs and Nutrition in modulating inflammation and chronic diseases. Nutrients 9(11):1168. https:\/\/doi.org\/10.3390\/nu9111168","journal-title":"Nutrients"},{"key":"2499_CR13","doi-asserted-by":"publisher","unstructured":"Atic AI, Thiele M, Munk A, Dalgaard LT (2023) Circulating miRNAs associated with nonalcoholic fatty liver disease. Am J Physiol Cell Physiol 1;324(2):C588-C602. https:\/\/doi.org\/10.1152\/ajpcell.00253.2022","DOI":"10.1152\/ajpcell.00253.2022"},{"issue":"9","key":"2499_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2013.86","volume":"9","author":"C Guay","year":"2013","unstructured":"Guay C, Regazzi R (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9(9):513\u2013521. https:\/\/doi.org\/10.1038\/nrendo.2013.86","journal-title":"Nat Rev Endocrinol"},{"key":"2499_CR15","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1017\/S0007114509993837","volume":"103","author":"JD Fern\u00e1ndez-Ballart","year":"2010","unstructured":"Fern\u00e1ndez-Ballart JD, Pi\u00f1ol JL, Zazpe I, Corella D, Carrasco P, Toledo E et al (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 103:1808\u20131816. https:\/\/doi.org\/10.1017\/S0007114509993837","journal-title":"Br J Nutr"},{"key":"2499_CR16","doi-asserted-by":"publisher","first-page":"e0210726","DOI":"10.1371\/journal.pone.0210726","volume":"14","author":"AM Galmes-Panades","year":"2019","unstructured":"Galmes-Panades AM, Konieczna J, Abete I, Colom A, Rosique-Esteban N, Zulet MA et al (2019) PREDIMED-Plus investigators lifestyle factors and visceral adipose tissue: results from the PREDIMED-PLUS study. PLoS ONE 14:e0210726. https:\/\/doi.org\/10.1371\/journal.pone.0210726","journal-title":"PLoS ONE"},{"issue":"23","key":"2499_CR17","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.3390\/nu14235160","volume":"14","author":"M Elorz","year":"2022","unstructured":"Elorz M, Benito-Boilos A, Marin BA, Del P\u00e9rez D\u00edaz N, Herrero JI, Monreal JI et al (2022) Neck circumference for NAFLD Assessment during a 2-Year nutritional intervention: the FLiO Study. Nutrients 14(23):5160. https:\/\/doi.org\/10.3390\/nu14235160","journal-title":"Nutrients"},{"key":"2499_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","volume":"43","author":"BE Ainsworth","year":"2011","unstructured":"Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C et al (2011) Compendium of physical activities: a second update of codes and MET values. Med Sci Sport Exerc 43:1575\u20131581. https:\/\/doi.org\/10.1249\/MSS.0b013e31821ece12","journal-title":"Med Sci Sport Exerc"},{"key":"2499_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/S0007114513002778","volume":"111","author":"R de la Iglesia","year":"2014","unstructured":"de la Iglesia R, Lopez-Legarrea P, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L et al (2014) A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic syndrome REduction in NAvarra (RESMENA) project. Br J Nutr 111:643\u2013652. https:\/\/doi.org\/10.1017\/S0007114513002778","journal-title":"Br J Nutr"},{"key":"2499_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"W Friedewald","year":"1972","unstructured":"Friedewald W, Levy R, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"issue":"2","key":"2499_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/diagnostics12020407","volume":"12","author":"E Martinou","year":"2022","unstructured":"Martinou E, Pericleous M, Stefanova I, Kaur V, Angelidi AM (2022) Diagnostic modalities of non-alcoholic fatty liver disease: from biochemical biomarkers to Multi-omics non-invasive approaches. Diagnostics (Basel) 12(2):407. https:\/\/doi.org\/10.3390\/diagnostics12020407","journal-title":"Diagnostics (Basel)"},{"key":"2499_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rgmxen.2024.09.002","author":"BA Priego-Parra","year":"2024","unstructured":"Priego-Parra BA, Triana-Romero A, Bernal-Reyes R, Icaza-Ch\u00e1vez ME, Mart\u00ednez-V\u00e1zquez SE, Amieva-Balmori M et al (2024) Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD. Rev Gastroenterol Mex (Engl Ed). https:\/\/doi.org\/10.1016\/j.rgmxen.2024.09.002. S2255-534X(24)00075\u2013\u20096","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"2499_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10620-016-4037-1","volume":"61","author":"S Kinner","year":"2016","unstructured":"Kinner S, Reeder SB, Yokoo T (2016) Quantitative imaging biomarkers of NAFLD. Dig Dis Sci 61:1337\u20131347. https:\/\/doi.org\/10.1007\/s10620-016-4037-1","journal-title":"Dig Dis Sci"},{"key":"2499_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7150\/ijms.28044","volume":"16","author":"I Cantero","year":"2019","unstructured":"Cantero I, Elorz M, Abete I, Marin BA, Herrero JI, Monreal JI et al (2019) Ultrasound\/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults. Int J Med Sci 16:75\u201383. https:\/\/doi.org\/10.7150\/ijms.28044","journal-title":"Int J Med Sci"},{"key":"2499_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.fmc.2017.03.001","volume":"24","author":"LC Rovira","year":"2017","unstructured":"Rovira LC, Majeed I, Escud\u00e9 AM, Pillasagua IA, Monserrat PT (2017) Esteatosis hep\u00e1tica: Diagn\u00f3stico Y Seguimiento. FMC Form M\u00e9dica Contin En Atenci\u00f3n Primaria 24:378\u2013389","journal-title":"FMC Form M\u00e9dica Contin En Atenci\u00f3n Primaria"},{"key":"2499_CR26","doi-asserted-by":"publisher","unstructured":"Liu H, Fu J, Hong R, Liu L, Li F (2015) Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis. PLoS One 1;10(7): e0127782. https:\/\/doi.org\/10.1371\/journal.pone.0127782","DOI":"10.1371\/journal.pone.0127782"},{"issue":"6","key":"2499_CR27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","volume":"63","author":"C Cassinotto","year":"2016","unstructured":"Cassinotto C, Boursier J, de L\u00e9dinghen V, Lebigot J, Lapuyade B, Cales P et al (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63(6):1817\u20131827. https:\/\/doi.org\/10.1002\/hep.28394","journal-title":"Hepatology"},{"key":"2499_CR28","doi-asserted-by":"publisher","first-page":"815651","DOI":"10.3389\/fimmu.2021.815651","volume":"12","author":"P Mart\u00ednez-Fleta","year":"2022","unstructured":"Mart\u00ednez-Fleta P, Vera-Tom\u00e9 P, Jim\u00e9nez-Fern\u00e1ndez M, Requena S, Roy-Vallejo E, Sanz-Garc\u00eda A (2022) A Differential signature of circulating miRNAs and cytokines between COVID-19 and Community-Acquired Pneumonia uncovers Novel Physiopathological mechanisms of COVID-19. Front Immunol 12:815651. https:\/\/doi.org\/10.3389\/fimmu.2021.815651","journal-title":"Front Immunol"},{"key":"2499_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Royal Stat Soc B"},{"key":"2499_CR30","doi-asserted-by":"crossref","unstructured":"Harrell F (2015) Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. In Regression Modeling Strategies. New York, NY: Springer","DOI":"10.1007\/978-3-319-19425-7"},{"key":"2499_CR31","doi-asserted-by":"publisher","unstructured":"Song SJ, Lai JC, Wong GL, Wong VW, Yip TC (2023) Can old NAFLD data be applied to the new MASLD definition? J Hepatol 2: S0168-8278(23)05000-6. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.021","DOI":"10.1016\/j.jhep.2023.07.021"},{"key":"2499_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of Liver diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"2499_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clnesp.2018.08.007","volume":"28","author":"VE Bianchi","year":"2018","unstructured":"Bianchi VE (2018) Weight loss is a critical factor to reduce inflammation. Clin Nutr ESPEN 28:21\u201335. https:\/\/doi.org\/10.1016\/j.clnesp.2018.08.007","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"2499_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.numecd.2023.09.009","volume":"34","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, He Y, Zhang L, Liu J, Bai Y, Wang M et al (2024) Effect of CVAI on the incidence of MASLD compared to BMI in populations with different body types: a prospective cohort study in China. Nutr Metab Cardiovasc Dis 34(2):307\u2013316. https:\/\/doi.org\/10.1016\/j.numecd.2023.09.009","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"2499_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/metabo12111044","volume":"12","author":"PN Brand\u00e3o-Lima","year":"2022","unstructured":"Brand\u00e3o-Lima PN, Carvalho GB, Payolla TB, Sarti FM, Rogero MM (2022) Circulating microRNA related to cardiometabolic risk factors for metabolic syndrome. Syst Rev Metabolites 12(11):1044. https:\/\/doi.org\/10.3390\/metabo12111044","journal-title":"Syst Rev Metabolites"},{"issue":"2","key":"2499_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21037\/hbsn.2018.12.05","volume":"8","author":"FM Trovato","year":"2019","unstructured":"Trovato FM, Castrogiovanni P, Malatino L, Musumeci G (2019) Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity. Hepatobiliary Surg Nutr 8(2):167\u2013169. https:\/\/doi.org\/10.21037\/hbsn.2018.12.05","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"2499_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00394-010-0115-x","volume":"50","author":"HH Hermsdorff","year":"2011","unstructured":"Hermsdorff HH, Zulet M\u00c1, Abete I, Mart\u00ednez JA (2011) A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight\/obese subjects. Eur J Nutr 50(1):61\u201369. https:\/\/doi.org\/10.1007\/s00394-010-0115-x","journal-title":"Eur J Nutr"},{"key":"2499_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12986-015-0033-2","volume":"24","author":"ND Guess","year":"2015","unstructured":"Guess ND, Dornhorst A, Oliver N, Bell JD, Thomas EL, Frost GS (2015) A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes. Nutr Metab (Lond) 24:12:36. https:\/\/doi.org\/10.1186\/s12986-015-0033-2","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"2499_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/nu9070667","volume":"28","author":"I Cantero","year":"2017","unstructured":"Cantero I, Abete I, Monreal JI, Martinez JA, Zulet MA (2017) Fruit Fiber Consumption specifically improves Liver Health Status in obese subjects under Energy Restriction. Nutrients 28(7):667. https:\/\/doi.org\/10.3390\/nu9070667","journal-title":"Nutrients"},{"key":"2499_CR40","doi-asserted-by":"publisher","first-page":"1053710","DOI":"10.1155\/2018\/1053710","volume":"2018","author":"F Shidfar","year":"2018","unstructured":"Shidfar F, Bahrololumi SS, Doaei S, Mohammadzadeh A, Gholamalizadeh M, Mohammadimanesh A (2018) The effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in nonalcoholic fatty liver disease patients undergoing low calorie Diet. Can J Gastroenterol Hepatol 2018:1053710. https:\/\/doi.org\/10.1155\/2018\/1053710","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2499_CR41","unstructured":"Vernaglione L (2009) The Mediterranean diet: a matter of history, tradition, culture and health. J Nephrol 22 Suppl 14:149\u2013\u200958"},{"key":"2499_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-018-4738-6","volume":"170","author":"BD Adams","year":"2018","unstructured":"Adams BD, Arem H, Hubal MJ, Cartmel B, Li F, Harrigan M, Sanft T et al (2018) Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Res Treat 170:55\u201367. https:\/\/doi.org\/10.1007\/s10549-018-4738-6","journal-title":"Breast Cancer Res Treat"},{"key":"2499_CR43","doi-asserted-by":"publisher","unstructured":"Falzone L, Grimaldi M, Celentano E, Augustin LSA, Libra M (2020) Identification of modulated MicroRNAs associated with breast cancer, diet, and physical activity. Cancers (Basel) 8;12(9):2555. https:\/\/doi.org\/10.3390\/cancers12092555","DOI":"10.3390\/cancers12092555"},{"issue":"6","key":"2499_CR44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40618-020-01453-9","volume":"44","author":"G Catanzaro","year":"2021","unstructured":"Catanzaro G, Filardi T, Sabato C, Vacca A, Migliaccio S, Morano S et al (2021) Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies. J Endocrinol Invest 44(6):1159\u20131174. https:\/\/doi.org\/10.1007\/s40618-020-01453-9","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2499_CR45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/nu16111547","volume":"16","author":"AL Tobaruela-Resola","year":"2024","unstructured":"Tobaruela-Resola AL, Riezu-Boj JI, Milagro FI, Mogna-Pelaez P, Herrero JI, Elorz M et al (2024) Multipanel Approach including miRNAs, inflammatory markers, and depressive symptoms for metabolic dysfunction-Associated Steatotic Liver Disease diagnosis during 2-Year nutritional intervention. Nutrients 16(11):1547. https:\/\/doi.org\/10.3390\/nu16111547","journal-title":"Nutrients"},{"issue":"1","key":"2499_CR46","doi-asserted-by":"publisher","first-page":"18856","DOI":"10.1038\/s41598-019-55076-z","volume":"9","author":"Y Ando","year":"2019","unstructured":"Ando Y, Yamazaki M, Yamada H, Munetsuna E, Fujii R, Mizuno G et al (2019) Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population. Sci Rep 9(1):18856. https:\/\/doi.org\/10.1038\/s41598-019-55076-z","journal-title":"Sci Rep"},{"issue":"11","key":"2499_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/1751-2980.12185","volume":"15","author":"C Huang","year":"2014","unstructured":"Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ et al (2014) Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. J Dig Dis 15(11):614\u2013621. https:\/\/doi.org\/10.1111\/1751-2980.12185","journal-title":"J Dig Dis"},{"issue":"3","key":"2499_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.14744\/hf.2021.2021.0037","volume":"15","author":"H Merve Bayram","year":"2021","unstructured":"Merve Bayram H, Eren F, Esra Gunes F (2021) The relationship between polyphenols and miRNAs: a novel therapeutic strategy for metabolic associated fatty liver disease. Hepatol Forum 15(3):128\u2013136. https:\/\/doi.org\/10.14744\/hf.2021.2021.0037","journal-title":"Hepatol Forum"},{"key":"2499_CR49","doi-asserted-by":"publisher","unstructured":"He Z, Yang JJ, Zhang R, Li HT, Wu L, Jiang F et al (2019) Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population. J Dig Dis. 2019;20(4):189\u2013195. https:\/\/doi.org\/10.1111\/1751-2980.12716","DOI":"10.1111\/1751-2980.12716"},{"key":"2499_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mvr.2018.10.009","volume":"123","author":"T Donghui","year":"2019","unstructured":"Donghui T, Shuang B, Xulong L, Meng Y, Yujing G, Yujie H et al (2019) Improvement of microvascular endothelial dysfunction induced by exercise and diet is associated with microRNA-126 in obese adolescents. Microvasc Res 123:86\u201391. https:\/\/doi.org\/10.1016\/j.mvr.2018.10.009","journal-title":"Microvasc Res"},{"issue":"22","key":"2499_CR51","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.3390\/nu14224712","volume":"14","author":"J Valerio","year":"2022","unstructured":"Valerio J, Barabash A, Garcia de la Torre N, De Miguel P, Melero V, Del Valle L et al (2022) The relationship between serum adipokines, miR-222-3p, miR-103a-3p and glucose regulation in pregnancy and two to three years post-delivery in women with gestational diabetes Mellitus adhering to Mediterranean Diet recommendations. Nutrients 14(22):4712. https:\/\/doi.org\/10.3390\/nu14224712","journal-title":"Nutrients"},{"issue":"1","key":"2499_CR52","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1038\/s41598-021-94115-6","volume":"11","author":"TH Kim","year":"2021","unstructured":"Kim TH, Lee Y, Lee YS, Gim JA, Ko E, Yim SY et al (2021) Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease. Sci Rep 11(1):14639. https:\/\/doi.org\/10.1038\/s41598-021-94115-6","journal-title":"Sci Rep"},{"issue":"5","key":"2499_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","volume":"64","author":"CJ Pirola","year":"2015","unstructured":"Pirola CJ, Fern\u00e1ndez Gianotti T, Casta\u00f1o GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M et al (2015) Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut 64(5):800\u2013812. https:\/\/doi.org\/10.1136\/gutjnl-2014-306996","journal-title":"Gut"},{"key":"2499_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","volume":"424","author":"H Yamada","year":"2013","unstructured":"Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K et al (2013) Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 424:99\u2013103. https:\/\/doi.org\/10.1016\/j.cca.2013.05.021","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2499_CR55","doi-asserted-by":"publisher","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","volume":"10","author":"PP Becker","year":"2015","unstructured":"Becker PP, Rau M, Schmitt J, Malsch C, Hammer C, Bantel H et al (2015) Performance of serum microRNAs\u2013\u2009122, -192 and\u2013\u200921 as biomarkers in patients with Non-alcoholic Steatohepatitis. PLoS ONE 10(11):e0142661. https:\/\/doi.org\/10.1371\/journal.pone.0142661","journal-title":"PLoS ONE"},{"issue":"8","key":"2499_CR56","doi-asserted-by":"publisher","first-page":"e105192","DOI":"10.1371\/journal.pone.0105192","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan Y, Ge G, Pan T, Wen D, Gan J (2014) A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE 9(8):e105192. https:\/\/doi.org\/10.1371\/journal.pone.0105192","journal-title":"PLoS ONE"},{"issue":"6","key":"2499_CR57","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/nu16060770","volume":"16","author":"M DeLucas","year":"2024","unstructured":"DeLucas M, S\u00e1nchez J, Palou A, Serra F (2024) The impact of Diet on miRNA Regulation and its implications for health: a systematic review. Nutrients 16(6):770 Published 2024 Mar 7. https:\/\/doi.org\/10.3390\/nu16060770","journal-title":"Nutrients"},{"key":"2499_CR58","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.arr.2022.101649","volume":"79","author":"T Ruskovska","year":"2022","unstructured":"Ruskovska T, Budi\u0107-Leto I, Corral-Jara KF, Ajd\u017eanovi\u0107 V, Arola-Arnal A, Bravo F al (2022) Systematic analysis of nutrigenomic effects of polyphenols related to cardiometabolic health in humans - evidence from untargeted mRNA and miRNA studies. Ageing Res Rev 79:101649. https:\/\/doi.org\/10.1016\/j.arr.2022.101649","journal-title":"Ageing Res Rev"},{"key":"2499_CR59","doi-asserted-by":"publisher","unstructured":"Gomez Ribot D, Diaz E, Fazio MV, G\u00f3mez HL, Fornes D, Macchi SB et al (2020) An extra virgin olive oil-enriched diet improves maternal, placental, and cord blood parameters in GDM pregnancies. Diabetes Metab Res Rev. 2020 36(8): e3349. https:\/\/doi.org\/10.1002\/dmrr.3349","DOI":"10.1002\/dmrr.3349"},{"issue":"7","key":"2499_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.molonc.2016.03.005","volume":"10","author":"N Vigneron","year":"2016","unstructured":"Vigneron N, Meryet-Figui\u00e8re M, Guttin A, Issartel JP, Lambert B, Briand M et al (2016) Towards a new standardized method for circulating miRNAs profiling in clinical studies: interest of the exogenous normalization to improve miRNA signature accuracy. Mol Oncol 10(7):981\u2013992. https:\/\/doi.org\/10.1016\/j.molonc.2016.03.005","journal-title":"Mol Oncol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02499-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T08:44:23Z","timestamp":1743324263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02499-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02499-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was performed under the principles of the Declaration of Helsinki, and it was approved by the Ethics Committee of the University of Navarra (ref. 54\/2015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all the participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}